Biopsy Devices Market, By Product Type (Procedure Tray, Needle Based Biopsy Instruments, Liquid Biopsy Instruments, Biopsy Table, Biopsy Forceps, Others), By Biopsy Type (Bone marrow biopsy, Cone biopsy, Excisional biopsy, Liquid biopsy, Needle biopsy, Ot

A biopsy is a medical procedure performed to diagnose diseases by examining the tissues or cells of organs or tumors. Biopsy devices are minimally invasive tools used to collect tissue samples from affected areas of the body. The global biopsy devices market has been witnessing tremendous growth, attributed to the rising incidence of cancer and increasing demand for minimally invasive diagnostic procedures. Factors such as a growing aging population, a preference for early disease diagnosis, and treatment and technological advancements leading to improved biopsy tools are contributing to market expansion. However, factors like complications associated with biopsy procedures and a strict regulatory framework for the approval of new biopsy products can present major challenges. Overall, with increased awareness about early screening and diagnosis of diseases, the biopsy devices market is expected to witness steady growth over the forecast period.

Market Dynamics

The global biopsy devices market is primarily driven by the increasing prevalence of cancer worldwide. Changing lifestyle habits leading to a rising risk of chronic diseases, a growing elderly population susceptible to targeted diseases, and the benefits offered by minimally invasive techniques are major factors fueling demand for biopsy procedures. However, high costs associated with biopsy devices, a dearth of skilled professionals, and complications pertaining to biopsy techniques can restrict market growth.

Ongoing research for the development of advanced biopsy tools, untapped potential in emerging markets, and favorable reimbursement scenarios present new opportunities. In addition, the launch of innovative products by key market players is anticipated to drive the market development over the forecast period. For instance, in September 2022, Merit Medical Systems, Inc., a leading global manufacturer and marketer of healthcare technology, announced the commercial release of the TEMNO Elite Soft Tissue Biopsy System in the U.S., the latest addition to Merit's extensive line of biopsy devices.

Key features of the study

• This report provides an in-depth analysis of the global biopsy devices market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global biopsy devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Merit Medical Systems, Inc, Hologic, Inc., Becton, Dickinson and Company, Medtronic plc, Stryker Corporation, Leica Biosystems Nussloch GmbH, Gallini Srl, TSK Laboratory, Remicalm, Meditech Devices, Agilent Technologies Inc., Guardant Health, Inc., Agena Bioscience, nRichDX, Epic Sciences, Inc., Predicine, Inc. , Argon Medical Devices , Cook Medical, Hologic Inc., Gallini Medical, and Intact Medical Corporation.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global biopsy devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biopsy devices market.

• Biopsy Devices Market, By Product Type
• Procedure Tray
• Needle Based Biopsy Instruments
• Liquid Biopsy Instruments
• Biopsy Table
• Biopsy Forceps
• Others
• Biopsy Devices Market, By Biopsy Type
• Bone marrow biopsy
• Cone biopsy
• Excisional biopsy
• Liquid biopsy
• Needle biopsy
• Others
• Biopsy Devices Market, By Application
• Prostate
• Endometrial
• Liver
• Heart
• Others
• Biopsy Devices Market, By End User
• Hospitals & Clinics
• Diagnostic Labs
• Academic & Research Institutes
• Biopsy Devices Market, By Region
• North America
• U.S.
• Canada
• Latin America
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Europe
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• South Africa
• North Africa
• Central Africa
• Company Profiles
• Merit Medical Systems, Inc.
• Hologic, Inc.
• Becton, Dickinson and Company
• Medtronic plc
• Stryker Corporation
• Leica Biosystems Nussloch GmbH
• Gallini Srl
• TSK Laboratory
• Remicalm
• Meditech Devices
• Agilent Technologies Inc.
• Guardant Health, Inc.
• Agena Bioscience
• nRichDX
• Epic Sciences, Inc.
• Predicine, Inc.
• Argon Medical Devices
• Cook Medical
• Hologic Inc.
• Gallini Medical
• Intact Medical Corporation